BE887224A - Nouveaux derives anticoagulants de l'agmatine et leur procede de preparation - Google Patents

Nouveaux derives anticoagulants de l'agmatine et leur procede de preparation

Info

Publication number
BE887224A
BE887224A BE1/10111A BE1010111A BE887224A BE 887224 A BE887224 A BE 887224A BE 1/10111 A BE1/10111 A BE 1/10111A BE 1010111 A BE1010111 A BE 1010111A BE 887224 A BE887224 A BE 887224A
Authority
BE
Belgium
Prior art keywords
agmatin
novel
preparation
anticoagulant
derivatives
Prior art date
Application number
BE1/10111A
Other languages
English (en)
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of BE887224A publication Critical patent/BE887224A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069—Ser-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BE1/10111A 1979-06-12 1981-01-26 Nouveaux derives anticoagulants de l'agmatine et leur procede de preparation BE887224A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79GO1449A HU178398B (en) 1979-06-12 1979-06-12 Process for producing new agmatine derivatives of activity against haemagglutination

Publications (1)

Publication Number Publication Date
BE887224A true BE887224A (fr) 1981-07-27

Family

ID=10996896

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/10111A BE887224A (fr) 1979-06-12 1981-01-26 Nouveaux derives anticoagulants de l'agmatine et leur procede de preparation

Country Status (17)

Country Link
US (1) US4346078A (fr)
JP (1) JPS5764653A (fr)
AT (1) AT384228B (fr)
AU (1) AU535688B2 (fr)
BE (1) BE887224A (fr)
CA (1) CA1158641A (fr)
CH (1) CH649561A5 (fr)
DE (1) DE3108810A1 (fr)
DK (1) DK150204C (fr)
FR (1) FR2491463B1 (fr)
GB (1) GB2085444B (fr)
HU (1) HU178398B (fr)
IL (1) IL62018A (fr)
IT (1) IT1168107B (fr)
NL (1) NL8100391A (fr)
SE (1) SE452326B (fr)
SU (1) SU1178322A3 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995023609A1 (fr) * 1994-03-04 1995-09-08 Eli Lilly And Company Agents inhibiteurs de l'agregation plaquettaire

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE968808C (de) * 1949-11-01 1958-04-03 Hermann Schilling Dipl Ing Baeuerliches Motorvielfachgeraet mit einachsigem Motorgrundgeraet
US4088040A (en) * 1977-01-03 1978-05-09 Ross Myring Brian 360° Cable actuating lever
IT1219846B (it) * 1988-02-24 1990-05-24 Consiglio Nazionale Ricerche Nuovi derivati guandinici ad attivita' ipotensia,composizione che li contengono e relativo procedimento di estrazione e purificazione da materiale botanico
FR2656608B1 (fr) * 1989-12-28 1992-04-24 Roussel Uclaf Nouvelles polyamines benzoylees, leur procede de preparation et leur application comme fongicides.
US5430023A (en) * 1990-09-28 1995-07-04 Eli Lilly And Company Tripeptide antithrombotic agents
IL99527A (en) * 1990-09-28 1997-08-14 Lilly Co Eli Tripeptide antithrombotic agents
US5252566A (en) * 1991-11-12 1993-10-12 Eli Lilly And Company Antithrombotic agents
US5416093A (en) * 1991-11-12 1995-05-16 Eli Lilly And Company Antithrombotic agents
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
SE507295C2 (sv) * 1992-01-18 1998-05-11 Thyssen Nordseewerke Gmbh Värmeisoleringsformkroppar
US5583146A (en) * 1992-12-02 1996-12-10 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
US6534536B1 (en) 1994-03-16 2003-03-18 Bristol-Myers Squibb Company Alkylsulfonamido heterocyclic thrombin inhibitors
AU675981B2 (en) * 1992-12-02 1997-02-27 Bristol-Myers Squibb Company Guanidinyl-substituted heterocyclic thrombin inhibitors
WO1994025051A1 (fr) * 1993-04-30 1994-11-10 Merck & Co., Inc. Inhibiteurs de thrombine
SE9900043D0 (sv) * 1999-01-11 1999-01-11 Astra Ab New use
SE9301912D0 (sv) * 1993-06-03 1993-06-03 Ab Astra Process for the production of aminoalkylguandines
US6984627B1 (en) 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
US5783563A (en) * 1993-06-03 1998-07-21 Astra Aktiebolag Method for treatment or prophylaxis of venous thrombosis
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
SE9301911D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptide derivatives
GB9318637D0 (en) * 1993-09-08 1993-10-27 Ferring Res Ltd Enzyme inhibitors
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
US5436229A (en) * 1994-03-04 1995-07-25 Eli Lilly And Company Bisulfite adducts of arginine aldehydes
US5488037A (en) * 1994-03-04 1996-01-30 Eli Lilly And Company Antithrombotic agents
CA2143533A1 (fr) * 1994-03-04 1995-09-05 Kenneth D. Kurz Agents antithrombotiques
US5484772A (en) * 1994-03-04 1996-01-16 Eli Lilly And Company Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5439888A (en) * 1994-03-04 1995-08-08 Eli Lilly And Company Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5691356A (en) * 1994-03-21 1997-11-25 Bristol-Myers Squibb Company Disubstituted heterocyclic thrombin inhibitors
US5561146A (en) * 1994-06-10 1996-10-01 Bristol-Myers Squibb Company Modified guanidino and amidino thrombin inhibitors
DE4421052A1 (de) * 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
US5498724A (en) * 1994-06-28 1996-03-12 Aktiebolaget Astra Pyrazoleamidine compounds
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
CN1198839C (zh) * 1995-02-17 2005-04-27 艾伯特有限及两合公司 作为凝血酶抑制剂的新的二肽脒类
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
TW541316B (en) * 1995-12-21 2003-07-11 Astrazeneca Ab Prodrugs of thrombin inhibitors
US5811402A (en) * 1996-03-22 1998-09-22 Eli Lilly And Company Antithrombotic diamides
SE9602263D0 (sv) 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives
US5863929A (en) 1996-06-25 1999-01-26 Eli Lilly And Company Anticoagulant agents
US6200967B1 (en) 1996-06-25 2001-03-13 Eli Lilly And Company Anticoagulant agents
SE9602646D0 (sv) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds
US5798377A (en) * 1996-10-21 1998-08-25 Merck & Co., Inc. Thrombin inhibitors
AR013084A1 (es) 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
SE9704543D0 (sv) 1997-12-05 1997-12-05 Astra Ab New compounds
BR9907112A (pt) 1998-01-26 2000-10-24 Basf Ag Composto, medicamento, e, uso de um composto
IL139162A0 (en) 1998-04-24 2001-11-25 Dimensional Pharm Inc Amidinohydrazone, alkoxyguanidine and aminoguanidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
SE9804313D0 (sv) * 1998-12-14 1998-12-14 Astra Ab New compounds
ES2295004T3 (es) 1999-01-13 2008-04-16 Astrazeneca Ab Nuevos derivados amidinobencilaminicos y su uso como inhibidores de trombina.
AR023510A1 (es) * 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
SE0001803D0 (sv) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
US6433186B1 (en) 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
US7129233B2 (en) * 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US6528503B2 (en) 2000-12-18 2003-03-04 Merck & Co., Inc. Thrombin inhibitors
WO2002050056A1 (fr) 2000-12-18 2002-06-27 Merck & Co., Inc. Derives de benzylamine et leur utilisation comme inhibiteurs de thrombine
WO2002064559A2 (fr) 2001-02-09 2002-08-22 Merck & Co., Inc. Inhibiteurs de thrombine
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
US7615527B2 (en) * 2001-07-06 2009-11-10 Oregon Health & Science University Peptides which modulate blood coagulation and methods of use thereof
US7084134B2 (en) * 2002-05-02 2006-08-01 Merk & Co., Inc. Thrombin inhibitors
SE0201374D0 (sv) * 2002-05-06 2002-05-06 Astrazeneca Ab Pharmaceutical combination
SE0201659D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
SE0201661D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab New salts
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
TW200827336A (en) * 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030
CN102464701B (zh) 2010-11-08 2015-10-21 上海医药工业研究院 一类新型化合物、其制备方法及用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177098B (en) * 1979-01-04 1981-07-28 Gyogyszerkutato Intezet Process for producing new peptidyl-n-carboxy-l-arginin-a

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995023609A1 (fr) * 1994-03-04 1995-09-08 Eli Lilly And Company Agents inhibiteurs de l'agregation plaquettaire
AU684918B2 (en) * 1994-03-04 1998-01-08 Astrazeneca Ab Antithrombotic agents
AU684918C (en) * 1994-03-04 2003-05-08 Astrazeneca Ab Antithrombotic agents

Also Published As

Publication number Publication date
SU1178322A3 (ru) 1985-09-07
GB2085444B (en) 1984-02-15
CA1158641A (fr) 1983-12-13
FR2491463A1 (fr) 1982-04-09
DE3108810A1 (de) 1982-05-19
IL62018A0 (en) 1981-02-27
AU6672581A (en) 1982-04-22
IT8120107A0 (it) 1981-03-04
DK150204B (da) 1987-01-05
NL8100391A (nl) 1982-05-03
GB2085444A (en) 1982-04-28
AT384228B (de) 1987-10-12
IT1168107B (it) 1987-05-20
SE8100302L (sv) 1982-04-08
DK23981A (da) 1982-04-08
ATA43681A (de) 1987-03-15
AU535688B2 (en) 1984-03-29
IL62018A (en) 1984-03-30
DK150204C (da) 1987-10-19
FR2491463B1 (fr) 1984-08-17
JPS5764653A (en) 1982-04-19
HU178398B (en) 1982-04-28
SE452326B (sv) 1987-11-23
CH649561A5 (en) 1985-05-31
US4346078A (en) 1982-08-24

Similar Documents

Publication Publication Date Title
BE887224A (fr) Nouveaux derives anticoagulants de l'agmatine et leur procede de preparation
BE880844A (fr) Nouveaux derives de peptidyl-arginine-aldehydes et procede de preparation de ceux-ci
BE882704A (fr) Nouveaux derives de omega-(4-diphenylmethyl-piperidino)-alcanophenones et leur procede de preparation
FR2449699B1 (fr) Polyetherpolyamides et leur procede de preparation
BE864488A (fr) Nouveaux derives phenoxybenzyloxycarbonyliques substitues leur procede de preparation et leur application comme insecticides et acaricides
BE882703A (fr) Nouveaux derives de omega-(4-diphenylmethyl-piperidino)-1-phenylalcanols et leur procede de preparation.
FR2384753B1 (fr) Nouveaux thiols et leur procede de preparation
MC1316A1 (fr) Ion nouveaux derives de flavone et procede pour leur preparat0
FR2496667B1 (fr) Nouveaux phenoxyalcoxysilanes et leur procede de preparation
FR2506306B1 (fr) Nouveaux derives de l'amidinopiperidine, leur procede de preparation et leur application en therapeutique
BE875998A (fr) Membranes d'ultrafiltration et leur procede de preparation
BE893707R (fr) Azabicyclohexanes et procede de leur preparation
BE889049A (fr) Nouvelles quinoxaline-2-yl-ethenylcetones et leur procede de preparation
BE882133A (fr) Derives d'acides 1-omega-mercaptoacyl)-4,5-dihydropyrazole-5-carboxyliques et leur procede de preparation
FR2571052B1 (fr) Derives de 1,3-oxazolidine-2-one et leur procede de preparation
BE885946A (fr) Nouvelles pyridothienotriazines et leur procede de preparation
BE887423A (fr) Nouveaux agents anti-rhinovirus et leur procede de preparation
BE884620A (fr) Nouveaux derives d'halovincamone, leur procede de preparation et medicaments les contenant
BE884652R (fr) Phenoxyalcoyl trialcoxysilanes et leur procede de preparation
FR2341568A1 (fr) Nouveaux d'homo-steroides et leur procede de preparation
MC1387A1 (fr) Nouveaux derives de phenoxyaminopropanol et leur preparation
FR2572405B1 (fr) Nouveaux derives de la phenethylaminoalcoyle-6 furo-(3,4-c)-pyridine et leur procede de preparation
BE882675A (fr) Nouveaux derives de la benzo-as-triazine, leur procede de preparation et medicaments les contenant
BE889504A (fr) 6-alkyl-2-penems et leur procede de preparation
FR2477142B1 (fr) Nouveaux derives de la nitrosouree, leur procede de preparation et leur application en therapeutique

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: RICHTER GEDEON VEGYESZETI GYAR RT

Effective date: 19880131